Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease
Authors:
Open Access
- 28 September 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Outside of the ongoing COVID-19 pandemic, tuberculosis is the leading cause of infectious disease mortality globally. Currently, there is no commercially available point-of-care diagnostic that is rapid, inexpensive, and highly sensitive for the diagnosis of active tuberculosis disease. Here we describe the development and optimization of a novel, highly sensitive prototype bioelectronic tuberculosis antigen (BETA) assay to detect tuberculosis-specific antigen, CFP10, in small-volume serum and urine samples. In this proof-of-concept study we evaluated the performance of the BETA assay using clinical specimens collected from presumptive tuberculosis patients from three independent cohorts. Circulating CFP10 antigen was detected in ALL serum (n = 19) and urine (n = 3) samples from bacteriologically confirmed tuberculosis patients who were untreated or had less than one week of treatment at time of serum collection, successfully identifying all culture positive tuberculosis patients. No CFP10 antigen was detected in serum (n = 7) or urine (n = 6) samples from individuals who were determined to be negative for tuberculosis disease. Additionally, antigen quantification using the BETA assay of paired serum samples collected from tuberculosis patients (n = 8) both before and after treatment initiation, indicate consistently declining within-person levels of CFP10 antigen during treatment. This novel, low-cost assay demonstrates potential as a rapid, non-sputum-based, point-of-care tool for the diagnosis of tuberculosis disease.Keywords
Funding Information
- This study was funded by Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P30AI036214-25)
This publication has 29 references indexed in Scilit:
- Xpert MTB/RIF for tuberculosis testing: access and price in highly privatised health marketsThe Lancet Global Health, 2016
- Clinical immunosensing of tuberculosis CFP-10 antigen in urine using interferometric optical fiber arraySensors and Actuators B: Chemical, 2015
- Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and ProspectsThe Journal of Infectious Diseases, 2015
- Tuberculosis diagnostics: which target product profiles should be prioritised?European Respiratory Journal, 2014
- TUBERCULOSIS IN CHILDRENMediterranean Journal of Hematology and Infectious Diseases, 2013
- Systematic Review and Meta-Analysis of Antigen Detection Tests for the Diagnosis of TuberculosisClinical and Vaccine Immunology, 2011
- Sensitive immunoassays of nitrated fibrinogen in human biofluidsTalanta, 2010
- Development of an Electrochemical Immunosensor for Fumonisins Detection in FoodsToxins, 2010
- Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changesThe Lancet, 2007
- Comparison of Blocking Agents for an Elisa for LpsJournal of Immunoassay, 2000